Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer’s Disease

13 Jan 2021

Abstract excerpt

Alzheimer's disease (AD) is a chronic neurodegenerative disease that has been recognized as one of the most intractable medical problems with heavy social and economic costs. Amyloid-β (Aβ) has been identified as a major factor that participates in AD progression through its neurotoxic effects. The major mechanism of Aβ-induced neurotoxicity is by interacting with membrane receptors and subsequent triggering of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cholinesterase and Neurodegenerative Diseases
Share to Neuroscience and Neuropharmacology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33459712
DOI: 10.3233/jad-200851

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer’s DiseasePMID 33459712Read ↗

ABC Transporters Are Key Players in Alzheimer’s DiseaseSemantic proximity Read ↗

Role of ABC Transporters in the Pathogenesis of Alzheimer’s DiseaseSemantic proximity Read ↗

Alzheimer’s and ABC transporters — new opportunities for diagnostics and treatmentSemantic proximity Read ↗

ABC Transporters and the Alzheimer’s Disease EnigmaSemantic proximity Read ↗

Molecular Targets in Alzheimer’s Disease: From Pathogenesis to TherapeuticsSemantic proximity Read ↗

Strategies to gain novel Alzheimer’s disease diagnostics and therapeutics using modulators of ABCA transportersSemantic proximity Read ↗

G Protein-Coupled Receptors (GPCRs) in Alzheimer’s Disease: A Focus on BACE1 Related GPCRsSemantic proximity Read ↗

The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer’s DiseaseSemantic proximity Read ↗

Disease‐modifying therapies in Alzheimer's diseaseSemantic proximity Read ↗

Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug DevelopmentSemantic proximity Read ↗

A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapySemantic proximity Read ↗

Intracellular A? and its Pathological Role in Alzheimer's Disease: Lessons from Cellular to Animal ModelsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.